Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy NeoGenomics (NEO) stocks in Canada
Learn how to easily invest in NeoGenomics stocks.
NeoGenomics is a diagnostics & research business based in the US. NeoGenomics stocks (NEO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $43.59 – a decrease of 8.35% over the previous week. NeoGenomics employs 2,100 staff and has a trailing 12-month revenue of around $509.7 million.
How to buy NeoGenomics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – NEO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
CIBC Investor's Edge
- Easy to use platform
- Low fees
- Student and young investor discounts
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
What's in this guide?
- Can I buy shares in NeoGenomics?
- Has coronavirus impacted NeoGenomics shares?
- NeoGenomics shares summary
- Compare share dealing platforms
- Is NeoGenomics stock a buy or sell?
- NeoGenomics performance over time
- Are NeoGenomics shares over-valued?
- NeoGenomics's financials
- How volatile are NeoGenomics shares?
- Does NeoGenomics pay a dividend?
- Have NeoGenomics shares ever split?
- Other common questions
NeoGenomics stock price (NASDAQ:NEO)Use our graph to track the performance of NEO stocks over time.
NeoGenomics shares at a glance
|Latest market close||$17.34|
|52-week range||$6.00 - $19.51|
|50-day moving average||$14.28|
|200-day moving average||$10.65|
|Wall St. target price||$20.18|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.21|
Buy NeoGenomics stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy NeoGenomics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
NeoGenomics price performance over time
Historical closes compared with the close of $17.34 from 2023-03-27
|1 week (2023-03-22)||-4.25%|
|1 month (2023-03-01)||4.58%|
|3 months (2022-12-25)||N/A|
|6 months (2022-09-29)||100.23%|
|1 year (2022-03-25)||-1.42%|
|2 years (2021-03-29)||-60.69%|
|3 years (2020-03-27)||25.71|
|5 years (2018-03-28)||111.46%|
Is NeoGenomics stock undervalued or overvalued?
Valuing NeoGenomics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NeoGenomics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
NeoGenomics's PEG ratio
NeoGenomics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.02. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into NeoGenomics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$509.7 million|
|Gross profit TTM||$187.9 million|
|Return on assets TTM||-5.37%|
|Return on equity TTM||-13.7%|
|Market capitalisation||$2.3 billion|
TTM: trailing 12 months
NeoGenomics share dividends
We're not expecting NeoGenomics to pay a dividend over the next 12 months.
Have NeoGenomics's shares ever split?
NeoGenomics's shares were split on a 1:100 basis on 16 April 2003. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NeoGenomics shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for NeoGenomics shares which in turn could have impacted NeoGenomics's share price.
NeoGenomics share price volatility
Over the last 12 months, NeoGenomics's shares have ranged in value from as little as $6 up to $19.51. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NeoGenomics's is 1.1245. This would suggest that NeoGenomics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited.
Stocks similar to NeoGenomics
NeoGenomics in the news
NeoGenomics to Host Investor Day on April 4, 2023
Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care
NeoGenomics' (NASDAQ:NEO) growing losses don't faze investors as the stock grows 4.7% this past week
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.Read more…
Best stock app for beginners
The best stock trading app for beginners is easy to use and offers free trades.Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.Read more…
More guides on Finder
How to buy Neuraxis (NRXS) stock in Canada when it goes public
Everything we know about the Neuraxis IPO plus information on how to buy in.
How to buy Brera (BREA) stock in Canada
Everything we know about the Brera IPO plus information on how to buy in.
How to buy TXO Energy (TXO) stock in Canada
Everything we know about the TXO Energy IPO plus information on how to buy in.
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
How to buy Torex Gold stock in Canada
Steps to owning and managing TXG stock, with 24-hour and historical pricing before you buy.
Best stock app for beginners
The best stock trading app for beginners is easy to use and offers free trades.
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
3 upcoming IPOs to watch in March 2023
An healthcare company, NFT tech developer and baby products retailer are among the IPOs expected to take place this month.
What are stocks?
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
Best time to buy stocks
The best time to buy stocks could be right after an IPO, during expansion periods or when other investors are buying or selling.